MetaCap

Savara (SVRA) News

NASDAQ: SVRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

4.26-0.95 (-18.23%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

SVRA news summary

We found 4 recent headlines mentioning Savara (SVRA): 3 in the past week and 4 in the past 30 days, most often from Nasdaq, Seeking Alpha, Investing.com. SVRA is making an outsized move today, down 18.23% at $4.26, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Savara drops after FDA says it will not meet molgramostim BLA action date", was published by Seeking Alpha on Nov 20, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Savara headlines

Stocks mentioned alongside SVRA

Compare SVRA